M

Main Line Health

Biomedical research division advancing cancer science

Nurse Practitioner - Hematology and Medical Oncology

Full-Time
No salary listed
Entry, Junior, Mid
Master's
Paoli, PA, USA
In Person
Medical, Clinical & VeterinaryAdvanced Practice Providers

About the job

Requirements
  • Completion of a Nurse Practitioner program is required.
  • A Master of Science in Nursing is required.
  • Licensure by the Pennsylvania State Board of Nursing Examiners as a Certified Registered Nurse Practitioner is required.
  • Provider Basic Life Support certification from the American Heart Association or American Red Cross is required.
  • Advanced Cardiovascular Life Support certification is required.
  • Pediatric Advanced Life Support may be required.
  • Successful completion of the Main Line Health credentialing process through the Medical Staff office, with temporary or permanent privileges approved, is required.
Responsibilities
  • Perform medical diagnosis or prescribe medical, therapeutic, or corrective measures in collaboration with attending physicians and residents.
  • Lead quality and evidence-based care initiatives to achieve optimal patient outcomes.
  • Enhance communication among physicians, family members, and the healthcare team.
Desired Qualifications
  • Two years of Nurse Practitioner experience in an inpatient setting is preferred; hematology/oncology experience is highly preferred.
  • A minimum of two years of nursing experience in hematology/oncology is preferred.
  • New graduates may be considered if they have prior hematology/oncology nursing experience and inpatient clinical rotations.

About the company

Lankenau Institute for Medical Research (LIMR) is the research division of Main Line Health that conducts cancer and biomedical research and translates basic science into clinical applications. LIMR studies cell growth and cancer biology, develops discoveries in the lab, and collaborates to move findings into patient care within the health system. It differs from other research centers by its long history as one of the first U.S. cancer-focused institutes, its integration within a hospital-based health system, and its track record of translational research—turning lab findings into clinical therapies and practices. The institute aims to improve patient outcomes by turning basic science into usable medical treatments and interventions for cancer and related diseases.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Lancaster, Pennsylvania

Founded

1927

Get referred to Main Line Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Fitch kept Main Line Health at AA with a stable outlook on October 28, 2025.
  • June 2026 revenue reached $2.1 billion, aided by Crozer closures shifting regional demand.
  • Paoli’s June 16, 2026 expansion adds 108 beds and supports higher-acuity volume growth.

What critics are saying

  • The January 2025 200-person layoff exposed reimbursement pressure and overhead dependence.
  • The October 2025 NLRB case with Local 835 signals ongoing labor friction at Lankenau.
  • The August 2026 whistleblower lawsuit over cardiac complications threatens trust, referrals, and surgeon recruitment.

What makes Main Line Health unique

  • LIMR gives Main Line Health a rare translational research engine inside a hospital system.
  • Paoli, Lankenau, Bryn Mawr, and Riddle create a tightly integrated Philadelphia suburban network.
  • The 2026 Saint Joseph’s exclusive-provider deal expands brand visibility beyond traditional hospital care.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Pension
  • 403(b) Retirement Plan
  • Unlimited Paid Time Off
  • Tuition Reimbursement
  • Wellness Program
  • Family Planning Benefits

Growth & Insights and Company News

Headcount

6 month growth

4%

1 year growth

4%

2 year growth

4%
PR Newswire
Nov 22nd, 2024
Independence Blue Cross Launches Epic Payer Platform To Transform Care Coordination And Boost Member Health Outcomes

PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) is implementing the Epic Payer Platform with health systems and providers in its network to streamline data exchange, close gaps in care, and improve health outcomes for members. Epic Payer Platform is part of Epic, a global healthcare technology company. The platform helps facilitate data exchange and workflow processes for providers and health plans, giving them the insights they need to make care decisions while also saving them time. "We're excited about the implementation of Epic Payer Platform with Drexel Medicine, Jefferson Health, Main Line Health, and Penn Medicine being the first to join us in this transformation. We look forward to more of our health care partners signing on as well," said Michael Vennera, executive vice president and chief strategy, technology, and operations officer at Independence Blue Cross

Managed Healthcare Executive
Feb 16th, 2022
Lankenau Institute For Medical Research hired George Prendergast as president and CEO on Jan 1st 04'.

When George Prendergast was appointed president and CEO of the Lankenau Institute of Medical Research (LIMR) in 2004, he coined the term “acapreneurial” as a mashup for the model he wanted to implement — inventions and startup incubation alongside traditional academic goals of research, new knowledge and its validation.